Skip to content
Yog Pharma
Anti-infectivesTriazole antifungal

Fluconazole is a triazole antifungal indicated for vaginal, oropharyngeal and esophageal candidiasis and cryptococcal meningitis. We supply it to US manufacturers of tablets, oral suspension and injection.

CAS86386-73-4306.3 g/molC13H12F2N6O
2D structure of Fluconazole.

Data from PubChem (CID 3365) and FDA’s substance registry

CAS number

86386-73-4

Molecular formula

C13H12F2N6O

Molecular weight

306.3g/mol

FDA UNII

IUPAC name

2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol

InChIKey

RFHAOTPXVQNOHP-UHFFFAOYSA-N

Appearance
White or almost white crystalline powder.
Solubility
Slightly soluble in water. Freely soluble in methanol, soluble in alcohol and acetone, and sparingly soluble in isopropanol.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

Has more than one polymorph. State the form, and whether you need oral or injection grade.

On the US market

Reference product
DiflucanNDA 019949
Approved ANDAs
19 with a marketed product
Approved forms and strengths
  • Tablet 50 mg, 100 mg, 150 mg, 200 mg
  • Injection 100 mg/50 mL, 200 mg/100 mL, 400 mg/200 mL
  • Powder for oral suspension 50 mg/5 mL, 200 mg/5 mL

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com